Plasma Copy Number Alteration-Based Prognostic and Predictive Multi-Gene Risk Score in Metastatic Castration-Resistant Prostate Cancer.

Cancers (Basel) · 2022 · PMC9562906 · PMID 36230636

Europe PMC DOI

hedged sentence

0.0610

closest p · 1.2× alpha

0.0610

boldest claim

The sentences

borderline significantp = 0.061so close (0.05 < p ≤ 0.1)

This analysis showed a significant decrease of the copy number in AR ( p = 0.001) and COL22A1 ( p = 0.037) and a borderline significant increase of the copy numbers in PTEN ( p = 0.061) in the responders at the 3 month treatment (paired t-test).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.